Horizon Technology Finance and Monroe Capital closed an initial $40 million senior credit facility for OSSIO, with an additional $10 million available to support future growth.
OSSIO is pursuing the development of the first credible replacement for metal implants in the global orthopedic fixation market with OSSIOfiber Intelligent Bone Regeneration Technology. The company conducts product development and manufacturing in Caesarea, Israel, with commercial operations based in Palmetto, FL.
“We are thrilled to partner with Horizon Technology Finance and Monroe Capital on this growth capital investment. We look forward to executing on our strategy to expand our orthopedic fixation technology globally,” commented Brian Verrier, Chief Executive Officer of OSSIO. “This partnership combines deep healthcare technology expertise with growth capital. Financing from the Horizon and Monroe platform provides the resources needed to accelerate expansion while preserving the company’s mission of transforming the orthopedic experience for patients.”
Horizon Technology Finance and Monroe Capital closed an initial $40 million senior credit facility for OSSIO, with an additional $10 million available to support future growth.
OSSIO is pursuing the development of the first credible replacement for metal implants in the global orthopedic fixation market with OSSIOfiber Intelligent Bone...
Horizon Technology Finance and Monroe Capital closed an initial $40 million senior credit facility for OSSIO, with an additional $10 million available to support future growth.
OSSIO is pursuing the development of the first credible replacement for metal implants in the global orthopedic fixation market with OSSIOfiber Intelligent Bone Regeneration Technology. The company conducts product development and manufacturing in Caesarea, Israel, with commercial operations based in Palmetto, FL.
“We are thrilled to partner with Horizon Technology Finance and Monroe Capital on this growth capital investment. We look forward to executing on our strategy to expand our orthopedic fixation technology globally,” commented Brian Verrier, Chief Executive Officer of OSSIO. “This partnership combines deep healthcare technology expertise with growth capital. Financing from the Horizon and Monroe platform provides the resources needed to accelerate expansion while preserving the company’s mission of transforming the orthopedic experience for patients.”
Copy to clipboard 
